Severe acute respiratory syndrome-associated coronavirus IVDs
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
28-05-2020
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
Roche Diagnostics Australia Pty Limited
Class:
Class 3
Manufactured by:
Roche Diagnostics GmbH Sandhofer Strasse 116, Mannheim, D-68305 Germany
Therapeutic area:
CT772 - Severe acute respiratory syndrome-associated coronavirus IVDs
Therapeutic indications:
IVDs that are intended to be used in testing to provide information about infection with or exposure to Severe acute respiratory syndrome-associated coronavirus (SARS-CoV)
Authorization status:
A
Authorization date:
2020-05-20
